GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kubota Pharmaceutical Holdings Co Ltd (TSE:4596) » Definitions » ROCE %

Kubota Pharmaceutical Holdings Co (TSE:4596) ROCE % : -52.94% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kubota Pharmaceutical Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kubota Pharmaceutical Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -52.94%.


Kubota Pharmaceutical Holdings Co ROCE % Historical Data

The historical data trend for Kubota Pharmaceutical Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kubota Pharmaceutical Holdings Co ROCE % Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only -32.66 -33.58 -49.61 -48.01 -43.58

Kubota Pharmaceutical Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.67 -33.29 -33.32 -61.58 -52.94

Kubota Pharmaceutical Holdings Co ROCE % Calculation

Kubota Pharmaceutical Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-1480.228/( ( (4419.755 - 360.827) + (3016.84 - 282.914) )/ 2 )
=-1480.228/( (4058.928+2733.926)/ 2 )
=-1480.228/3396.427
=-43.58 %

Kubota Pharmaceutical Holdings Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-1362.652/( ( (3016.84 - 282.914) + (2693.04 - 279.531) )/ 2 )
=-1362.652/( ( 2733.926 + 2413.509 )/ 2 )
=-1362.652/2573.7175
=-52.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kubota Pharmaceutical Holdings Co  (TSE:4596) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Kubota Pharmaceutical Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Kubota Pharmaceutical Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kubota Pharmaceutical Holdings Co (TSE:4596) Business Description

Traded in Other Exchanges
N/A
Address
3-7-1 Kasumigaseki, 4th Floor,Kasumigaseki Tokyu Building, Chiyoda-ku, Tokyo, JPN, 150-6018
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.

Kubota Pharmaceutical Holdings Co (TSE:4596) Headlines

No Headlines